 Connection
Laura Saba to Risk Factors
This is a "connection" page, showing publications Laura Saba has written about Risk Factors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.043 |
|
|
|
-
Calabrese A, Basile V, Puglisi S, Perotti P, Pia A, Saba L, Berchialla P, Porpiglia F, Veltri A, Volante M, Reimondo G, Berruti A, Terzolo M. Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. Eur J Endocrinol. 2019 Jun 01; 180(6):387-396.
Score: 0.015
-
Zuo L, Saba L, Lin X, Tan Y, Wang K, Krystal JH, Tabakoff B, Luo X. Significant association between rare IPO11-HTR1A variants and attention deficit hyperactivity disorder in Caucasians. Am J Med Genet B Neuropsychiatr Genet. 2015 Oct; 168(7):544-56.
Score: 0.011
-
Zuo L, Saba L, Wang K, Zhang X, Krystal JH, Tabakoff B, Luo X. Exome-wide association study of replicable nonsynonymous variants conferring risk for alcohol dependence. J Stud Alcohol Drugs. 2013 Jul; 74(4):622-5.
Score: 0.010
-
Dovio A, Data V, Carignola R, Calzolari G, Vitetta R, Ventura M, Saba L, Severino A, Angeli A. Circulating osteoprotegerin and soluble RANK ligand in systemic sclerosis. J Rheumatol. 2008 Nov; 35(11):2206-13.
Score: 0.007
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|